McKesson/$MCK
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About McKesson
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Ticker
$MCK
Sector
Primary listing
NYSE
Employees
44,000
Headquarters
Website
McKesson Metrics
BasicAdvanced
$103B
25.88
$32.12
0.41
$3.06
0.39%
Price and volume
Market cap
$103B
Beta
0.41
52-week high
$895.58
52-week low
$570.51
Average daily volume
561K
Dividend rate
$3.06
Financial strength
Current ratio
0.88
Quick ratio
0.475
Long term debt to equity
-1,343.772
Total debt to equity
-1,722.318
Dividend payout ratio (TTM)
8.98%
Interest coverage (TTM)
25.50%
Profitability
EBITDA (TTM)
5,605
Gross margin (TTM)
3.44%
Net profit margin (TTM)
1.04%
Operating margin (TTM)
1.55%
Effective tax rate (TTM)
18.49%
Revenue per employee (TTM)
$8,800,000
Management effectiveness
Return on assets (TTM)
4.06%
Return on equity (TTM)
-262.61%
Valuation
Price to earnings (TTM)
25.879
Price to revenue (TTM)
0.268
Price to book
-59.27
Price to tangible book (TTM)
-5.98
Price to free cash flow (TTM)
17.294
Free cash flow yield (TTM)
5.78%
Free cash flow per share (TTM)
48.064
Dividend yield (TTM)
0.37%
Forward dividend yield
0.39%
Growth
Revenue change (TTM)
17.23%
Earnings per share change (TTM)
66.19%
3-year revenue growth (CAGR)
12.48%
10-year revenue growth (CAGR)
7.51%
3-year earnings per share growth (CAGR)
32.31%
10-year earnings per share growth (CAGR)
15.44%
3-year dividend per share growth (CAGR)
14.80%
10-year dividend per share growth (CAGR)
11.42%
What the Analysts think about McKesson
Analyst ratings (Buy, Hold, Sell) for McKesson stock.
McKesson Financial Performance
Revenues and expenses
McKesson Earnings Performance
Company profitability
McKesson News
AllArticlesVideos
McKesson Corporation Completes Divestiture of Norwegian Operations
Business Wire·22 hours ago
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
Business Wire·3 weeks ago
Final Trades: Lockheed Martin, QXO and McKesson Corporation
CNBC Television·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for McKesson stock?
McKesson (MCK) has a market cap of $103B as of January 31, 2026.
What is the P/E ratio for McKesson stock?
The price to earnings (P/E) ratio for McKesson (MCK) stock is 25.88 as of January 31, 2026.
Does McKesson stock pay dividends?
Yes, the McKesson (MCK) stock pays dividends to shareholders. As of January 31, 2026, the dividend rate is $3.06 and the yield is 0.39%. McKesson has a payout ratio of 8.98% on a trailing twelve-month basis.
When is the next McKesson dividend payment date?
The next McKesson (MCK) dividend payment is scheduled for April 01, 2026.
What is the beta indicator for McKesson?
McKesson (MCK) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.